<DOC>
	<DOCNO>NCT02103985</DOCNO>
	<brief_summary>The purpose study evaluate effect food bioavailability single oral dose JNJ-39823277 active metabolite .</brief_summary>
	<brief_title>A Study Effect Food Pharmacokinetics Single JNJ-39823277 ( TPI-1062 ) Dose Healthy Participants</brief_title>
	<detailed_description>This randomize ( study medication assign chance ) , open-label ( people know identity intervention ) , single-center , 2 treatment-sequence , crossover study ( method use switch participant one treatment arm another clinical study ) . The study consist 3 phase : screening phase ( within 21 day medication administration ) , 2-period open-label treatment phase , participant receive 1 2 open-label treatment sequence , end-of-study withdrawal assessment ( within 7-11 day last dose study medication ) . Participants randomly assign 1 2 treatment-sequences : Treatment Sequence AB ( dose feed [ high fat diet ] condition follow dose fast [ without food ] condition ) Treatment Sequence BA ( dose fast condition follow dose feed condition ) . Study medication administration separate washout period ( period receive treatment ) 7 14 day . The study duration participant approximately 6 week .</detailed_description>
	<criteria>Participant must healthy male nonlactating healthy female Agrees protocoldefined use effective contraception If woman , must negative serum ßhuman chorionic gonadotropin ( ßhCG ) pregnancy test screen Day 1 treatment period Agree abstain medication ( except allow birth control ) , include prescription nonprescription ( include vitamin natural herbal remedy ) A history clinically significant gastrointestinal , especially peptic ulceration , gastrointestinal bleeding , ulcerative colitis , Crohn 's disease Irritable Bowel Syndrome , renal , hepatic , neurologic , hematologic , endocrine , oncologic , pulmonary , immunologic , psychiatric , especially past history depression , suicidal ideation suicidal attempt , cardiovascular disease Acute diarrhea constipation 7 day predict first study day . If screen occur &gt; 7 day first study day , criterion determine Day 1 Participant donate blood within 90 day plasma within 30 day study dose Participant use overthecounter prescription medication , include vitamin , within 14 day prior study exception acetaminophen Participant consume product contain grapefruit juice grapefruit , Seville oranges ( eg , orange marmalade ) , quinine ( eg , tonic water ) , xanthine ( eg , chocolate , caffeine containing product ) within 24 hour ( 72 hour case grapefruit juice Seville orange ) prior start study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Healthy</keyword>
	<keyword>JNJ-39823277</keyword>
	<keyword>JNJ-40917006</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>